EMA — authorised 26 March 2021
- Marketing authorisation holder: Incyte Biosciences Distribution B.V.
- Status: approved
🇪🇺 Pemazyre in European Union
EMA authorised Pemazyre on 26 March 2021
Marketing authorisation
Pemazyre in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in European Union
Frequently asked questions
Is Pemazyre approved in European Union?
Yes. EMA authorised it on 26 March 2021.
Who is the marketing authorisation holder for Pemazyre in European Union?
Incyte Biosciences Distribution B.V. holds the EU marketing authorisation.